A Peptide Found in Schizophrenia and Autism Causes Behavioral Changes in Rats
- 1 March 1999
- journal article
- Published by SAGE Publications in Autism
- Vol. 3 (1), 85-95
- https://doi.org/10.1177/1362361399003001007
Abstract
In a previous study we showed that β-casomorphin-7 (β-CM7) is taken up by brain regions relevant to schizophrenia and autism. The present experiment was designed to find whether β-CM7 has any behavioral or analgesic effects in rats. About 65 seconds after treatment with different doses of β-CM7, rats became restless and ran violently, with teeth chattering and with rapid respiration. Seven minutes later, the rats became inactive with less walking, distancing themselves from the other rat in the same cage, and sitting in, or putting their head against, the corner of the cage. The sound response was reduced and social interaction was absent. One hour later, the rats showed hyperdefensiveness. The above behavioral effects of β-CM7 did not occur when rats were pretreated with naloxone (2 mg/kg, IP). The rats receiving saline did not show any behavioral changes throughout the 2 hour period of observation. β-CM7 also demonstrated analgesic effects, which could be blocked by naloxone. The results suggest that β-CM7 may play a role in behavioral disorders such as autism and schizophrenia.This publication has 13 references indexed in Scilit:
- Neutral endopeptidase inhibition increases the urinary excretion and plasma levels of endothelinMetabolism, 1992
- Urinary peptides in schizophrenia and depressionStress Medicine, 1985
- CSF and plasma beta-casomorphin-like opioid peptides in postpartum psychosisAmerican Journal of Psychiatry, 1984
- A peptide-containing fraction of plasma from schizophrenic patients which binds to opiate receptors and induces hyper-reactivity in ratsNeuroscience, 1982
- Opioid activities of β-casomorphinsLife Sciences, 1981
- Endogenous opioids and social behaviorNeuroscience & Biobehavioral Reviews, 1981
- A peptide-containing fraction in the urine of schizophrenic patients which stimulates opiate receptors and inhibits dopamine uptakeNeuroscience, 1979
- Naloxone's antagonism of rigidity but not explosive motor behavior: Possible evidence for two types of mechanisms underlying the actions of opiates and opioidsBehavioral Biology, 1978
- Effects of methionine-enkephalin and morphine on spontaneous locomotor activity: Antagonism by naloxonePharmacology Biochemistry and Behavior, 1978
- Neuroleptic activity of the neuropeptide β-LPH62–77 ([Des-Tyr1]γ-endorphin; DTγE)European Journal of Pharmacology, 1978